---
title: 'Software Daily Summary: What Happened on November 12, 2026'
headline: Latch Bio benchmark puts AI agents through structural-biology tasks
description: SecureBio also began tracking changes in models’ biological-safety scores
  over time.
url: https://thebench.bio/news/software/2026-11-12
topic: software
date: '2026-11-12'
covers:
- '2026-11-12'
date_published: '2026-11-12T12:03:28Z'
date_modified: '2026-11-13T00:04:03Z'
tags:
- Industry
- Software
sources: 2
publisher: TheBench.Bio
---

# Software Daily Summary: What Happened on November 12, 2026

**Latch Bio benchmark puts AI agents through structural-biology tasks**

SecureBio also began tracking changes in models’ biological-safety scores over time.

## Today in brief

Latch Bio tested AI agents on 58 structural-biology tasks involving pathogen targets. The leading standard configuration passed 43.7% of them. [1] SecureBio began publishing repeated BioTIER tests, which found safety-score changes in both directions across models from four developers. [2]

## Also worth knowing

- Latch Bio tested 20 models. Fable 5.2 with Claude Code led standard configurations, with a 95% confidence interval of 32.3% to 55.1%. [1]
- BioTIER contains 542 prompts across three biological-risk levels. SecureBio measured Gemini 3.1 Pro’s refusal score rising from 46% to 74%, while Grok 4.7’s fell from 88.5% to about 80%. [2]

## The day in numbers

- **43.7%**: Top standard pass rate in Latch Bio’s 58-task structural-biology benchmark, achieved by Fable 5.2 with Claude Code. [1]
- **46% to 74%**: Change in Gemini 3.1 Pro’s BioTIER refusal score in SecureBio’s repeated tests. [2]

## Also published

- [Why So Many Patients From Underrepresented Groups Are Never Asked to Join a Trial](<https://www.appliedclinicaltrialsonline.com/view/why-many-patients-underrepresented-groups-never-asked-join-trial>), Applied Clinical Trials
- [The hardest part of becoming an AI-first company: It’s not the technology](<https://pharmaphorum.com/digital/hardest-part-becoming-ai-first-company-its-not-technology>), pharmaphorum
- [Whoop just launched a social network](<https://techcrunch.com/2026/11/12/whoop-just-launched-a-social-network/>), TechCrunch Biotech and Health
- [Vibe-coding: Structure Lens](<https://macinchem.org/2026/11/12/vibe-coding-structure-lens/>), Mac in Chem

## Sources

1. [BioSecBench-Structure: Can AI Agents Analyze Molecular Structures?](<https://blog.latch.bio/p/biosecbench-structure-can-ai-agents>), Latch Bio, 2026-11-12
2. [Longitudinal Tracking of BioTIER Performance](<https://securebio.substack.com/p/longitudinal-biotier>), SecureBio, 2026-11-12

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://blog.latch.bio/p/biosecbench-structure-can-ai-agents>
[2]: <https://securebio.substack.com/p/longitudinal-biotier>
